Genomic Health (GHDX)
Genomic Health Key Statistics
Pro Data ExportCurrent Valuation
| Market Cap | 1.042B |
| Enterprise Value | 999.46M |
| PE Ratio | 119.83 |
| PE 10 Pro | Go Pro |
| PEG Ratio | 2.663 |
| Price / Sales Ratio | 4.852 |
| Price / Book Value | 8.503 |
| EV / Revenues Pro | Go Pro |
| EV / EBITDA Pro | Go Pro |
| EV / EBIT Pro | Go Pro |
| Operating Earnings Yield Pro | Go Pro |
Dividends and Shares
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Dividend Date | |
| Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin | 84.05% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
| Profit Margin | 1.33% |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 5.979 |
| Debt to Equity Ratio | 0.00 |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | 20.95% |
| Year to Date Stock Returns | 36.86% |
| 1 Year Stock Returns | 27.34% |
| 3 Year Stock Returns | 79.12% |
| 52 Week High | 35.00 |
| 52 Week Low | 19.00 |
Income Statement
| Revenues TTM | 214.77M |
| Revenue Per Share TTM | 7.161 |
| Revenue Growth | 17.38% |
| Gross Profit TTM | 180.67M |
| EBITDA TTM Pro | Go Pro |
| Income from Cont. Ops Pro | Go Pro |
| Net Income TTM | 8.909M |
| Earnings Per Share TTM | 0.29 |
| Other Comprehensive Income Pro | Go Pro |
Cash Flow Statement
| Cash Investing TTM | -14.03M |
| Cash Financing TTM | 9.234M |
| Cash Operations TTM | 23.63M |
| Capital Expenditures | 2.342M |
Share Statistics
| Shares Outstanding | 29.99M |
Balance Sheet
| Cash and ST Investments | 101.84M |
| Total Assets | 146.58M |
| Liabilities | 24.02M |
| Book Value | 122.56M |
| Book Value per Share | 4.087 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
| Long Term Debt | 0.00 |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
You may also be interested in these GHDX related companies
GHDX News
NEW POST: "A Bit Too Rare" http://stks.co/3ySS $GENE $GHDX $MYGN $QQQ $ROSG $SPY
about 5 days ago by chessNwine
about 5 days ago by chessNwine
$GHDX Insider Buy: $5.4M of stock bought by Felix Baker between May 21, 2012 - May 22, 2012 http://stks.co/3xjR
about 6 days ago by MarketBrief
about 6 days ago by MarketBrief
$GHDX Insider Buy: $12.7M of stock bought by Felix Baker between May 14, 2012 - May 16, 2012 http://stks.co/3rdD
about 13 days ago by MarketBrief
about 13 days ago by MarketBrief
10 breakouts: $BONA, $GHDX. Two sub-$1 and no penny stocks. Slow day but no focus on weak stocks, just a lack of interest
about 15 days ago by fallondpicks
about 15 days ago by fallondpicks
Genomic Health, Marriott Vacations Worldwide Among Stocks Setting 52-Week Highs Monday
May 14, 4:32PM Fox Business
May 14, 4:32PM Fox Business
$GHDX Another Baker Brothers favorite, crushing it over the last 6 trading days. This kind of move & volume in this crappy market? Whats up?
about 15 days ago by PTSD_Trader
about 15 days ago by PTSD_Trader
Ruparelia's picks in diagnostic testing, robots and 3D printing: $GHDX $IRBT $SSYS $DDD http://stks.co/3nhk
about 16 days ago by covestor
about 16 days ago by covestor
$GHDX I like the volume/accumulation here. Keeping on watch list. New name for me. http://chart.ly/bl5p3dd
about 17 days ago by BrettPerlman
about 17 days ago by BrettPerlman
$GHDX Insider Buy: $3.4M of stock bought by Felix Baker between May 9, 2012 - May 11, 2012 http://stks.co/3nPM
about 18 days ago by MarketBrief
about 18 days ago by MarketBrief
$GHDX Insider Buy: $5.6M of stock bought by Felix Baker between May 4, 2012 - May 8, 2012 http://stks.co/3jWm
about 21 days ago by MarketBrief
about 21 days ago by MarketBrief
Canaccord Genuity Maintains a 'Hold' on Genomic Health (GHDX); Raising PT and Estimates
May 03, 9:44AM Street Insider
May 03, 9:44AM Street Insider
Genomic Health Announces First Quarter 2012 Financial Results and Business Progress
May 02, 4:01PM PR Newswire
May 02, 4:01PM PR Newswire
Genomic Health (GHDX) to Report New Data from Recent Oncotype DX Clinicals
Mar 21, 7:03AM Street Insider
Mar 21, 7:03AM Street Insider
$GHDX http://stks.co/2p6Y Continues to act well on nice price & volume profile. Back near HOD.
about 77 days ago by Fibline
about 77 days ago by Fibline
Baker Bros stake in $GHDX is now over 35% of the whole company. There's really only one way to sell out of a position like that one day.
about 79 days ago by bradloncar
about 79 days ago by bradloncar
RT @ElliotTurn: Best idea from Barron's= $GHDX, w/ Baker Bros. accumulating a massive stake in the provider of personalized genomics-based
about 80 days ago by WallStJesus
about 80 days ago by WallStJesus
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| GHDX | 34.75 | +0.19 | +0.55% | 1.036B |
| GGT | 6.72 | +0.08 | +1.20% | |
| GGR | 0.1999 | -0.00 | -0.05% | 19.83M |
| GGP | 17.08 | +0.27 | +1.61% | |
| FRT | 99.43 | +0.84 | +0.85% | 6.277B |
| FRS | 27.18 | -0.04 | -0.15% | 134.47M |
| FRP | 5.39 | -0.13 | -2.36% | |
| FRO | 5.31 | -0.07 | -1.30% | 418.89M |
| FORTY | 16.00 | -0.22 | -1.36% | 226.24M |
| FORR | 33.27 | -0.04 | -0.12% | 755.14M |
